Literature DB >> 18280611

Cytosolic DNA recognition for triggering innate immune responses.

Akinori Takaoka1, Tadatsudu Taniguchi.   

Abstract

The detection of microbial components by pattern recognition receptors (PRRs) and the subsequent triggering of innate immune responses constitute the first line of defense against infections. Recently, much attention has been focused on cytosolic nucleic acid receptors; the activation of these receptors commonly evokes a robust innate immune response, the hallmark of which is the induction of type I interferon (IFN) genes. In addition to receptors for RNA, receptors that detect DNA exposed in the cytosol and activate innate immune responses have long been thought to exist. Recently, DAI (DLM-1/ZBP1) has been identified as a candidate cytosolic DNA sensor. Cytosolic signaling by DNA-activated DAI (DLM-1/ZBP1) signaling results in activation of the two pathways of gene transcription critical to innate immune responses, the IRF and NF-kappaB pathways. In this review, we summarize our current view of activation mechanism and immunological roles of DAI (DLM-1/ZBP1) and related molecules. In addition, we also discuss the issue of self vs. non-self DNA recognition by DAI (DLM-1/ZBP1) and other DNA sensors in terms of the possible involvement in autoimmune abnormalities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18280611     DOI: 10.1016/j.addr.2007.12.002

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  33 in total

1.  Treatment with cationic liposome-DNA complexes (CLDCs) protects mice from lethal Western equine encephalitis virus (WEEV) challenge.

Authors:  Christopher H Logue; Aaron T Phillips; Eric C Mossel; Jeremy P Ledermann; Thomas Welte; Steve W Dow; Ken E Olson; Ann M Powers
Journal:  Antiviral Res       Date:  2010-05-07       Impact factor: 5.970

2.  The double-stranded RNA binding domain of the vaccinia virus E3L protein inhibits both RNA- and DNA-induced activation of interferon beta.

Authors:  Jean-Baptiste Marq; Stéphane Hausmann; Jeremy Luban; Daniel Kolakofsky; Dominique Garcin
Journal:  J Biol Chem       Date:  2009-07-07       Impact factor: 5.157

3.  Age-enhanced endoplasmic reticulum stress contributes to increased Atg9A inhibition of STING-mediated IFN-β production during Streptococcus pneumoniae infection.

Authors:  Dana N Mitzel; Virginia Lowry; Anushree C Shirali; Yushi Liu; Heather W Stout-Delgado
Journal:  J Immunol       Date:  2014-03-26       Impact factor: 5.422

4.  DNA-dependent activator of interferon-regulatory factors inhibits hepatitis B virus replication.

Authors:  Qi-Ying Chen; Ying-Hui Liu; Jian-Hua Li; Ze-Kun Wang; Jiang-Xia Liu; Zheng-Hong Yuan
Journal:  World J Gastroenterol       Date:  2012-06-14       Impact factor: 5.742

5.  RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate.

Authors:  Andrea Ablasser; Franz Bauernfeind; Gunther Hartmann; Eicke Latz; Katherine A Fitzgerald; Veit Hornung
Journal:  Nat Immunol       Date:  2009-07-16       Impact factor: 25.606

6.  Construction of a large scale integrated map of macrophage pathogen recognition and effector systems.

Authors:  Sobia Raza; Neil McDerment; Paul A Lacaze; Kevin Robertson; Steven Watterson; Ying Chen; Michael Chisholm; George Eleftheriadis; Stephanie Monk; Maire O'Sullivan; Arran Turnbull; Douglas Roy; Athanasios Theocharidis; Peter Ghazal; Tom C Freeman
Journal:  BMC Syst Biol       Date:  2010-05-14

7.  Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus.

Authors:  Laura Ahtiainen; Cristina Mirantes; Tiina Jahkola; Sophie Escutenaire; Iulia Diaconu; Pamela Osterlund; Anna Kanerva; Vincenzo Cerullo; Akseli Hemminki
Journal:  PLoS One       Date:  2010-11-05       Impact factor: 3.240

8.  Regulating immune response using polyvalent nucleic acid-gold nanoparticle conjugates.

Authors:  Matthew D Massich; David A Giljohann; Dwight S Seferos; Louise E Ludlow; Curt M Horvath; Chad A Mirkin
Journal:  Mol Pharm       Date:  2009 Nov-Dec       Impact factor: 4.939

9.  Non-clinical safety studies of IMT504, a unique non-CpG oligonucleotide.

Authors:  Raúl Franco; Juan M Rodriguez; Fernanda Elías; Andrés Hernando-Insúa; Juan Fló; Ricardo López; Carlos Nagle; Néstor Lago; Jorge Zorzopulos; David L Horn; Alejandro D Montaner
Journal:  Nucleic Acid Ther       Date:  2014-04-10       Impact factor: 5.486

10.  Interferon γ-inducible protein (IFI) 16 transcriptionally regulates type i interferons and other interferon-stimulated genes and controls the interferon response to both DNA and RNA viruses.

Authors:  Mikayla R Thompson; Shruti Sharma; Maninjay Atianand; Søren B Jensen; Susan Carpenter; David M Knipe; Katherine A Fitzgerald; Evelyn A Kurt-Jones
Journal:  J Biol Chem       Date:  2014-07-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.